Christopher Bruno

795 total citations
37 papers, 527 citations indexed

About

Christopher Bruno is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, Christopher Bruno has authored 37 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 17 papers in Pharmacology and 17 papers in Molecular Medicine. Recurrent topics in Christopher Bruno's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (17 papers) and Pneumonia and Respiratory Infections (12 papers). Christopher Bruno is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (17 papers) and Pneumonia and Respiratory Infections (12 papers). Christopher Bruno collaborates with scholars based in United States, Ireland and France. Christopher Bruno's co-authors include Jennifer A. Huntington, Elizabeth G. Rhee, Brian Yu, Ignacio Martín‐Loeches, Marin H. Kollef, Richard G. Wunderink, Nobuaki Shime, Álvaro Réa-Neto, Joan R. Butterton and Martin Nováček and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Lancet Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Christopher Bruno

35 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Bruno United States 12 357 302 252 192 106 37 527
Myra W. Popejoy United States 11 431 1.2× 396 1.3× 250 1.0× 228 1.2× 35 0.3× 20 620
Obiamiwe Umeh United States 6 462 1.3× 405 1.3× 297 1.2× 190 1.0× 43 0.4× 9 606
Jennifer A. Huntington United States 15 673 1.9× 578 1.9× 412 1.6× 294 1.5× 137 1.3× 26 847
Jiejun Du United States 10 500 1.4× 390 1.3× 275 1.1× 264 1.4× 56 0.5× 22 748
C. Angel Cooper United States 7 370 1.0× 299 1.0× 238 0.9× 124 0.6× 72 0.7× 8 611
Charudatt Shirwadkar Australia 6 184 0.5× 424 1.4× 308 1.2× 183 1.0× 51 0.5× 6 534
Sylva H. Collins United States 5 242 0.7× 215 0.7× 174 0.7× 137 0.7× 33 0.3× 8 409
Abel Jasovich Argentina 10 202 0.6× 226 0.7× 211 0.8× 89 0.5× 40 0.4× 22 439
Kate Sulham United States 10 252 0.7× 121 0.4× 257 1.0× 161 0.8× 73 0.7× 19 487
Jean Li Yan United States 13 234 0.7× 238 0.8× 226 0.9× 74 0.4× 32 0.3× 28 546

Countries citing papers authored by Christopher Bruno

Since Specialization
Citations

This map shows the geographic impact of Christopher Bruno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Bruno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Bruno more than expected).

Fields of papers citing papers by Christopher Bruno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Bruno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Bruno. The network helps show where Christopher Bruno may publish in the future.

Co-authorship network of co-authors of Christopher Bruno

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Bruno. A scholar is included among the top collaborators of Christopher Bruno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Bruno. Christopher Bruno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Winchell, Gregory A., Rik de Greef, Rebecca E. Wrishko, et al.. (2024). A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia. Antimicrobial Agents and Chemotherapy. 68(4). e0119723–e0119723. 3 indexed citations
3.
Roilides, Emmanuel, et al.. (2023). Subgroup analysis of phase 2 study of ceftolozane/tazobactam in neonates and young infants with pyelonephritis. Microbiology Spectrum. 11(5). e0180023–e0180023. 3 indexed citations
4.
Roilides, Emmanuel, Negar Ashouri, John S. Bradley, et al.. (2023). Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial. The Pediatric Infectious Disease Journal. 42(4). 292–298. 19 indexed citations
5.
Martín‐Loeches, Ignacio, Andrew F. Shorr, Richard G. Wunderink, et al.. (2023). Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial. Annals of Intensive Care. 13(1). 8–8. 8 indexed citations
6.
7.
8.
Bruno, Christopher & Witold J. Henisz. (2022). Environmental, Social, and Governance (ESG) Factors and Municipal Bond Yields. SSRN Electronic Journal. 2 indexed citations
9.
Bruno, Christopher, et al.. (2022). Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR). Annals of Clinical Microbiology and Antimicrobials. 21(1). 42–42. 7 indexed citations
10.
Bruno, Christopher, et al.. (2022). Walking the Talk: Valuing a Multi-Stakeholder Strategy. SSRN Electronic Journal.
11.
Paterson, David L., Matteo Bassetti, Mary Motyl, et al.. (2022). Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial. Journal of Antimicrobial Chemotherapy. 77(9). 2522–2531. 15 indexed citations
12.
Gao, Wei, Yogesh T. Patel, Zufei Zhang, et al.. (2022). Ceftolozane/Tazobactam Probability of Target Attainment in Patients With Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia. The Journal of Clinical Pharmacology. 63(3). 352–357. 6 indexed citations
13.
Timsit, Jean‐François, Jennifer A. Huntington, Richard G. Wunderink, et al.. (2021). Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial. Critical Care. 25(1). 290–290. 26 indexed citations
14.
Johnson, Matthew G., Christopher Bruno, Mariana Castanheira, et al.. (2021). Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP). International Journal of Antimicrobial Agents. 57(3). 106278–106278. 15 indexed citations
15.
Groll, Andreas H., Hisham Abdel‐Azim, Thomas Lehrnbecher, et al.. (2020). Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial. International Journal of Antimicrobial Agents. 56(3). 106084–106084. 32 indexed citations
16.
Huntington, Jennifer A., Brian Yu, Erin Jensen, et al.. (2020). Outcomes in Participants with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane/Tazobactam Treatment of Nosocomial Pneumonia (ASPECT-NP). Antimicrobial Agents and Chemotherapy. 64(12). 7 indexed citations
17.
Kollef, Marin H., Martin Nováček, Álvaro Réa-Neto, et al.. (2019). Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial. The Lancet Infectious Diseases. 19(12). 1299–1311. 230 indexed citations
18.
Bruno, Christopher, et al.. (2012). Attitudes of Housestaff toward a Prior-Authorization-Based Antibiotic Stewardship Program. Infection Control and Hospital Epidemiology. 33(4). 429–431. 11 indexed citations
19.
Bruno, Christopher, et al.. (2012). Assessing the Potential Effects of Climate Change on Species in the Cumberland Piedmont Network of the National Park Service. DukeSpace (Duke University). 1 indexed citations
20.
Curone, M., et al.. (1998). [Successful medical treatment of Candida tropicalis in prosthetic valve endocarditis].. PubMed. 58(3). 301–2. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Myra W. Popejoy Breakdown of academic impact, for papers by Obiamiwe Umeh Breakdown of academic impact, for papers by Jennifer A. Huntington Breakdown of academic impact, for papers by Jiejun Du Breakdown of academic impact, for papers by C. Angel Cooper Breakdown of academic impact, for papers by Charudatt Shirwadkar Breakdown of academic impact, for papers by Sylva H. Collins Breakdown of academic impact, for papers by Abel Jasovich Breakdown of academic impact, for papers by Kate Sulham Breakdown of academic impact, for papers by Jean Li Yan
Rankless by CCL
2026